PKvitality is a French health technology company developing K'Watch, a smartwatch designed to track glucose levels continuously and non-invasively for diabetic patients. The company's flagship product, K'Watch Glucose, is a continuous glucose monitoring (CGM) device in the form of a smartwatch. It utilizes a technology called SkinTaste, which involves micro-tips that painlessly examine the interstitial fluid under the skin to measure glucose levels.
The K'Watch Glucose has undergone three rounds of clinical trials, with the latest trial in July 2022 achieving a 16% margin of error, surpassing the initial target of 17-18%. This accuracy results from improvements made to the K'apsul patch and the algorithm used by the device. The smartwatch continuously monitors glucose levels and provides alerts for high or low levels, aiming to prevent hyper or hypoglycemic episodes.
PKvitality's mission is to enable individuals to actively contribute to their well-being through user-friendly products. The K'Watch Glucose aims to facilitate the lives of millions of diabetic patients by offering a painless and discreet CGM solution. The company is working toward validating the project and offering a CGM that meets the expectations of diabetic patients by being painless, adhesive-free, discreet, and ultra-practical. PKvitality targets making the K'Watch Glucose available by 2024.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.